Endocrine Principles and Signaling Mechanisms Flashcards
Hormone
- A chemical substance secreted by specialized cell types and carried by the blood stream to act on distant target cells.
- A key role is to implement homeostasis.
Homeostasis
- Defined as the maintenance of steady states in the body by coordinated physiological mechanisms.
- Regulate exchanges of matter and energy between the external enviroment and the internal enviroment of the body.
- Regulate exchanges between the intracellular environment with extracellular fluid and its components.

Hormonal
Direct Regulation
- Oxygen and carbon dioxide tensions
- Concentrations of glucose and other metabolites
- Osmotic pressure
- Ionic concentrations
- Temperature
Hormonal
Indirect Regulation
- Cellular proliferation
- Cellular differentiation
- Growth and maturation
- Reproduction
- Senescence
- Behavior
Sources of hormones
Produced by both endocrine glands and many cells with endocrine functions.

Hormones
Modes of Communication
- Local communication
- Autocrine
- Paracrine
- Distant communication
- Neuroendocrine
- Endocrine

Autocrine
Cell releases a chemical messenger that remains in the surrounding extracellular fluid and binds to a receptor on the surface of the same cell.
Ex. Eicosanoids including prostaglandins.
These hormones regulate local processes such as uterine smooth muscle contraction during pregnancy.
Paracrine
- The chemical messenger is released from a cell and act on a nearby cell after diffusing for a short distance.
- Hormones acting in this fashion can only affect the immediate environment.
- Extracellular enzymes rapidly destroy paracrine hormones to avoid their diffusion to distant sites.
- Ex. Nitric oxide
- Regulates the tone of smooth muscle cells among other effects.
Neuroendocrine
- Neurohormones produced by neurons and released through the axon into the blood stream to circulate and act on distant target cells.
- Ex. ADH and oxytocin by hypothalamus neurons.
Endocrine
- Endocrine glands and cells secrete hormones directly into the blood stream.
- Often through specialized portion of the plasma membrane located on one side of the cell body (cell polarization)
Hydrophilic hormones
- Dissolves easily in the blood because they are often polar and charged.
- Typically stored in secretory vesicles until secretion occurs.
- Includes amine hormones and peptide hormones.
- Unable to cross the plasma membrane so in order to transmit the signal they carry inside the cells two conditions are necessary:
- Receptor for the hormone on the cell surface
- Secondary messengers which transmit signal from the cell membrane to intracellular targets
Amine Hormones
- Catecholamine hormones
- Derived from amino acid tyrosine
- Includes:
- Dopamine and norepinephrine
- Neurotransmitters in CNS
- Epinephrine
- Exclusively produced outside of the CNS
- Dopamine and norepinephrine
Peptide Hormones
- Pituitary gland
- Produces peptide hormones which act as releasing factors (RF) acting on peripheral endocrine glands such as thyroid, gonads, and adrenal gland
- Endocrine Pancreas
- Produces insulin, glucagon, and several others
Insulin Processing
Typical example of peptide hormone processing.
- Pre-pro-insulin precursor located in the ER.
- There the C-peptide induces a particular 3D conformation which allows the cross-binding of the pro-insulin.
- Pro-insulin transferred to the golgi.
- There the C-peptide is cleaved off and included in secretory vesicles along with insulin.
- No physiological functions but can be measured in the plasma to provide indication of the amount of insulin secreted by the pancreas.
- A and B chains bound together forming insulin.
- There the C-peptide is cleaved off and included in secretory vesicles along with insulin.
Intracellular Signaling Machinery
-
Receptors: located on the plasma membrane and bind hydrophillic hormones.
- Ex. G-protein coupled receptors (GPCRs) and Tyrosine Kinase Receptors (TKRs).
-
Tranducers: molecular mediators which are tightly associated with the plasma membrane receptors.
- Ex. G-protein
-
Effectors: Enzymes responsible for receiving the input from transducers and produce the secondary messengers.
- Ex. Adenylyl cyclase and phospholipase C
-
Secondary messengers: carry the signal from the hormones (primary messenger) to intracelluar targets.
- Ex. cAMP, cGMP, IP3, DAG, Ca++, and arachidonic acid

G protein-coupled receptors
(GPRCs)
- Includes more than 1,000 types which use trimeric G proteins as transucers
- Share a very similar structure with:
- 7 transmembrane-spanning regions
- ligand-binding domain located on extracellular amino terminal
- G-protein binding site located on the intracellular carboxy-terminal
- The same receptor/hormone can activate different types of G-proteins in different cells/tissues and generate distinct cellular responses.
- Hormone binding induces a conformational change in the receptor which results in binding of intracellular portion with G-protein.
- Bound G-protein exchanges GDP for GTP and dissociates in alpha and beta-gamma subunits
- Each subunit will activate different effectors.
- Hydrolysis of GTP to GDP by the alpha subunit will then induce reassociation of the three subunits and displacement of the G-protein from the receptor.

Tyrosine Kinase Receptors
(TKRs)
- Less homogeneous than GPCRs
- Typically organized with a:
- Extracellular domain to bind the hormone
- Short transmembrane portion
- Cytoplasmic portion that contains a kinase domain
- TKRs exist as monomers and upon binding hormone commonly dimerize.
- Dimerization brings cytoplasmic tails of each receptor in close proximity and induces a conformational change causing activation of the kinase domain.
- Resulting trans-phosphorylation of cytoplasmic portions of each receptor generates docking sites for effectors molecules that bind through a specific sequence called a SH2-domain.
- Phosphorylation of the effectors activates them.

Hydrophobic Hormones
Properties
- Do not dissolve well in the blood because they are often nonpolar and uncharged.
- Requires carrier proteins to allow their transport in plasma.
- Cannot be contained in secretory vesicles and are almost always secreted from the producing cell immediately after synthesis.
Hydrophobic Hormone
Classes
Each class of hydrophobic hormones are derived from a common precursor.
-
Steroids derived from cholesterol.
- Glucocorticoids and mineralocorticoids.
-
Thyroid hormones derived from amino acid tyrosine
- These are stored within the producing cells despite hydrophobic nature.
-
Eicosanoids derived from arachidonic acids.
- Despite being hydrophobic, will bind and activate receptors on surface of target cells.
Type I
Intracellular Receptors
- Located in the cytosol
- Binds steroid hormones (glucocorticoids and mineralocorticoids)
- Hormones easily crosses the plasma membrane and binds to the cytosolic receptor.
- Hormone-receptor complex moves into the nucleus and binds to promoters → specific DNA sequences responsible for regulating gene expression.
- Bind via the Hormone Response Element (HRE) sequence in the promotor.
- Interaction with the promotor can inhibit gene expression but typically promotes expression of specific genes and production of mRNA.
- mRNA → proteins
- The synthesized proteins produce the response of the cell to the hormone.

Type II
Intracellular Receptors
- Receptors are located in the nucleus and are already bound to DNA.
- Inactive when unoccupied by the hormone and act as repressors of gene expression in this state.
- Binds Vit A & D, retinoids, and thyroid hormones.
- Hormones must enter the plasma membrane, travel through the cytoplasm, cross the nuclear envelope, and then bind to their receptors.
- Receptor activated after binding hormone are displaced from the DNA allowing gene expression.
Storage and Secretion of Hormones
- Hydrophobic hormones are not normally stored and simply diffuse out of the cell and into the plasma after production.
- Except thyroid hormone
- Hydrophillic hormones can be stored in cytoplasmic vesicles and accumulate until secretion triggered.
- Process of secretion
- Ligand binds cellular receptor.
- G-protein activated → turns on phospholipase C.
- PLC produces the secondary messenger inositol triphosphate (IP3).
- IP3 binds to receptors located on ER triggering release of Ca2+ into the cytosol.
- Increased intracellular [Ca2+] activates the fusion of hormone-containing vesicles with the plasma membrane and triggers secretion.
- The simultaneous production of additional secondary messengers (AMP and GMP) also capable of modulating the process of hormone secretion.
- Process of secretion

Additional regulation of hormonal secretion
- G-protein/IP3 regulation
- Pulsatile vs steady-state release
- Oscillating factors
- Development (growth vs maintenance)
- Menstrual cycle
- Seasonal
- Circadian or daily variance
- Feedback control
- Positive vs negative
Hormone Transport
- Majority of hydrophilic hormones (peptide and catecholamines) circulate in the plasma in their free form.
-
Hydrophobic hormones (steroids and thyroid hormones) circulate bound to specific globulins.
- Complexes increase solubility of hydrophobic hormones in plasma.
- Also increases a hormone’s distribution in different tissues.
- Only the free form of a hormone is active and capable of activating cellular responses.
Hormone Half-Life
Defined as the time needed for one-half of a hormone to disappear from the plasma.
- Half-life of a hydrophobic hormone is predominantly correlated to the percentage of it that is bound to carrier proteins at any given time.
- Because only free hormones are available to be degraded, successively cleared from the plasma, and secreted from the body.
- Hormones that circulate mostly bound to carrier proteins (hydrophobic ones) will have a longer half-life as compared to hormones that circulate in free form (hydrophilic ones).
Methods of hormone removal
- Uptake and degradation operated by target cells.
- Metabolic degradation (predominately by the liver).
- Urinary or biliary excretion.
Metabolic Clearance Rate
(MCR)
Measurement of the speed and efficiency of the elimination of a hormone from the plasma.

Radioimmunoassay
(RIA)
- Monoclonal antibodies bind to a radioactive form of the same hormone that needs to be measured in biological fluids.
- The hormone in the unknown sample will compete with the radioactive hormone in binding to the antibody.
- The higher the concentration of the hormone in the unknown sample, the lower the radioactivity in the antibody complex.
- Indicated by a RIA standard curve in which the non-radioactive hormone to be measured progressively reduces the concentrations of the radioactive hormone bound to the antibody depending on its concentration in the unknown sample.

Enzyme-linked Immunosorbent Assay
(ELISA)
- An antibody is bound to a substrate and captures the hormone from the biological sample.
- Another antibody - conjugated with an enzyme - will detect the captured hormone.
- Enzyme catalyzes a reaction in which a substrate is converted into a colored or fluorescent product.
- The intensity of the colorimetric or fluorescent reaction indicates the concentration of the hormone in the sample.

Hormonal Biological Assays
- Used to estimate the concentration of a biologically active hormone by comparing an unknown sample to standard concentrations.
- Necessary to obtain correct physiological or diganostic information when the activity of a hormone is not dependent on its concentration but on its physiological state
- Ex. a hormone whose activity is dependent on the level of glycosylation
Hormone Receptor Regulation
Receptor down-regulation and up-regulation determines dose-response relations and directly dictates the changes in responsiveness and sensivity to a hormone.
-
Down-regulation
- # of receptors for a given hormone expressed on the cell surface can decrease due to physiological and regulatory events as well as pathological conditions
- Ex. as a compensating response to exaggerated increases in the plasma levels of a hormone
- The binding of the hormone to its receptors induces the endocytosis of the receptor and/or its inactivation.
- Ex. as a compensating response to exaggerated increases in the plasma levels of a hormone
- Pathological conditions may be associated with auto-antibodies which target specific hormone receptors.
- Induces a down-regulation of the effects observed on targeted cells.
- Functional down-regulation may be associated with a reduced affinity of a hormone for its receptor even in the presence of a normal number of receptors on the cell surface.
- Ex. Insulin and Type II Diabetes
- # of receptors for a given hormone expressed on the cell surface can decrease due to physiological and regulatory events as well as pathological conditions
- Up-regulation:
- Can be the result of a compensatory measure in normal cells for a reduction in the levels of a hormone in the interstitial fluid.
- In cancer cells, over-expression of hormone receptors, often acting as oncogenes, can be observed.
Dose-Response Relationship
The relationship between the dose of a hormone and the resulting biological response observed in the target cells and the expected changes in body functions.
Dependent on the target cell’s responsiveness and sensivity to a hormone.
Responsiveness to a Hormone
- Indicates the maximum functional response that can be obtained by progressively increasing the concentration of a hormone.
- Depends on:
- The number of functional receptors expressed
- The maximum possible number of transducers, effectors, and secondary messengers that can be recruited by the receptors in a given time
- If there is a reduction in the responsiveness for a given hormone, then an increase in the hormone concentration will not produce any relevant increase in the biological response.
- Excess ligand cannot be matched by a comparable number of receptors or transducers.
PANEL A

Sensitivity to a hormone
- Defines the affinity between a hormone and its receptors.
- Sensitivity is measured as the concentration of a hormone capable of inducing 50% of the maximal response.
- A reduction in sensitivity is expressed as a shift to the right of the dose-response curve.
- Need for higher concentrations of a hormone in order to induce the 50% of maximal response.
- A reduction in sensitivity can be temporarily compensated for with an increase in hormone concentration.
PANEL B
